ANIMATION

Zirus Antivirotics

Share this animation:

Scientists at Zirus have been working on the development of a new class of antivirals. Using a platform called the “gene trap,” Zirus has uncovered hundreds of humans proteins essential for viral replication, in hopes that new drugs may be developed to help treat infection. This animation uses as example the life cycle of the H1N1 influenza-A virus, and depicts the methodology Zirus uses to find appropriate drug targets.

Animation from this video was used by Robert Krulwich of NPR for a story on how the flu virus invades your body.

Share It:
Contact XVIVO

Client


Zirus

I have had the pleasure of working closely with the XVIVO team for the past year and half as we prepared for launch. They have contributed to building a sound foundation for communicating our clinical messaging across multiple mediums and channels. XVIVO’s scientific rigor and technical expertise exceed any I have seen within the industry. The XVIVO team consists of highly professional engaging personnel that have mastered their respective areas of work. XVIVO are fun and engaging partners. The products that XVIVO consistently delivered elevated the power of our story.

Intuniv Marketing, Shire LLC.
Share this animation: